These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 11441524)
21. Hypofractionated and accelerated radiotherapy with amifostine cytoprotection (HypoARC): a new concept in radiotherapy and encouraging results in breast cancer. Koukourakis MI Semin Oncol; 2002 Dec; 29(6 Suppl 19):42-6. PubMed ID: 12577243 [TBL] [Abstract][Full Text] [Related]
22. The preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies by amifostine. Capizzi RL Semin Oncol; 1999 Apr; 26(2 Suppl 7):3-21. PubMed ID: 10348255 [TBL] [Abstract][Full Text] [Related]
23. The sulfhydryl containing compounds WR-2721 and glutathione as radio- and chemoprotective agents. A review, indications for use and prospects. Hospers GA; Eisenhauer EA; de Vries EG Br J Cancer; 1999 May; 80(5-6):629-38. PubMed ID: 10360638 [TBL] [Abstract][Full Text] [Related]
25. Antioxidants and other nutrients do not interfere with chemotherapy or radiation therapy and can increase kill and increase survival, part 1. Simone CB; Simone NL; Simone V; Simone CB Altern Ther Health Med; 2007; 13(1):22-8. PubMed ID: 17283738 [TBL] [Abstract][Full Text] [Related]
26. [Cytoprotective effects of amifostine in the treatment of tumors]. Burkon P; Petýrek P; Spurný V Vnitr Lek; 2003 Aug; 49(8):673-8. PubMed ID: 14518094 [TBL] [Abstract][Full Text] [Related]
27. Amifostine before chemotherapy: improved tolerance profile of the subcutaneous over the intravenous route. Koukourakis MI; Simopoulos C; Minopoulos G; Patlakas G; Polychronidis A; Limberis V; Romanides K; Pitiacoudis M; Manolas C Clin Cancer Res; 2003 Aug; 9(9):3288-93. PubMed ID: 12960114 [TBL] [Abstract][Full Text] [Related]
28. The potential of amifostine in high-dose chemotherapy and autologous hematopoietic stem cell transplantation. Phillips GL Semin Oncol; 2002 Dec; 29(6 Suppl 19):53-6. PubMed ID: 12577245 [TBL] [Abstract][Full Text] [Related]
29. Established and emerging uses of cytoprotection in head and neck cancer. Rosenthal DI Arch Otolaryngol Head Neck Surg; 2006 Feb; 132(2):129-30. PubMed ID: 16490868 [No Abstract] [Full Text] [Related]
30. Study of cisplatin-vinblastine plus amifostine in patients with locally advanced or metastatic non-small cell lung cancer. Thongprasert S; Chewaskulyong B J Med Assoc Thai; 2004 Oct; 87(10):1162-7. PubMed ID: 15560691 [TBL] [Abstract][Full Text] [Related]
31. Improved tolerability of amifostine with rapid infusion and optimal patient preparation. Boccia R Semin Oncol; 2002 Dec; 29(6 Suppl 19):9-13. PubMed ID: 12577237 [TBL] [Abstract][Full Text] [Related]
32. [Radioprotective effects on head and neck tumors of amifostine--a broad-spectrum cytoprotection]. Huang R; Yu H; Kuang A Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2002 Dec; 19(4):708-11. PubMed ID: 12561384 [TBL] [Abstract][Full Text] [Related]
33. Radioprotective effect of amifostine in patients with head and neck squamous cell carcinoma. Bourhis J; Rosine D Semin Oncol; 2002 Dec; 29(6 Suppl 19):61-2. PubMed ID: 12577247 [TBL] [Abstract][Full Text] [Related]
34. Amifostine and glutathione prevent ifosfamide- and acrolein-induced hemorrhagic cystitis. Batista CK; Mota JM; Souza ML; Leitão BT; Souza MH; Brito GA; Cunha FQ; Ribeiro RA Cancer Chemother Pharmacol; 2007 Jan; 59(1):71-7. PubMed ID: 16708234 [TBL] [Abstract][Full Text] [Related]
35. Blood thiols following amifostine and mesna infusions, a pediatric oncology group study. Souid AK; Fahey RC; Aktas MK; Sayin OA; Karjoo S; Newton GL; Sadowitz PD; Dubowy RL; Bernstein ML Drug Metab Dispos; 2001 Nov; 29(11):1460-6. PubMed ID: 11602522 [TBL] [Abstract][Full Text] [Related]
36. Amifostine protects against cisplatin-induced nephrotoxicity in a child with medulloblastoma. Hayek M; Srinivasan A Pediatr Hematol Oncol; 2003; 20(3):253-6. PubMed ID: 12637222 [No Abstract] [Full Text] [Related]
38. The cytoprotective effect of amifostine in acute radiation dermatitis: a retrospective analysis. Kouvaris J; Kouloulias V; Kokakis J; Matsopoulos G; Myrsini B; Vlahos L Eur J Dermatol; 2002; 12(5):458-62. PubMed ID: 12370135 [TBL] [Abstract][Full Text] [Related]
39. [Recommendations of the Working Group 'Supportive Massnahmen in der Onkologie' concerning the Clinical Use of Cytoprotectives]. Büntzel J; Bokemeyer C; Wagner W; Onkologie; 2001 Feb; 24(1):81-6. PubMed ID: 11441287 [No Abstract] [Full Text] [Related]
40. Re: Sodium thiosulfate in cisplatin overdose by Erdlenbruch B et al., Med Pediatr Oncol 2002;38:349-352. Bleyer A; Alberts DS Med Pediatr Oncol; 2003 Jun; 40(6):413; author reply 414. PubMed ID: 12692822 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]